Reuters logo
BRIEF-Beijing Beilu Pharmaceutical receives patent license
November 10, 2017 / 4:37 AM / 11 days ago

BRIEF-Beijing Beilu Pharmaceutical receives patent license

Nov 10(Reuters) - Beijing Beilu Pharmaceutical Co Ltd :

* Says co received a patent license (No. ZL 2015 1 0232933.8), named hydrobromide paroxetine-sec-butyl alcohol compound and preparation method thereof

* Says co received a patent license (No. ZL 2015 1 0232955.4), about preparation method thereof related hydrobromide

Source text in Chinese: goo.gl/rt7Hsw

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below